ELOXATIN Side Effects

7023666-9 | Abdominal Hernia, Anorectal Disorder, Haematemesis, Haematochezia, Hiatus Hernia, Nephrolithiasis, Neutropenia
on Sep 29, 2010 Female patient from UNITED STATES , weighting 231.5 lb, was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal hernia, anorectal disorder, haematemesis, haematochezia, hiatus hernia, nephrolithiasis, neutropenia. Eloxatin dosage: 184 Mg. Patient was hospitalized.

7019615-X | Encephalopathy, Status Epilepticus
Patient was taking Eloxatin (View Usage). Patient had the following side effects: encephalopathy, status epilepticus on Sep 24, 2010 from FRANCE Additional patient health information: Female patient , 66 years of age, . Eloxatin dosage: . During the same period patient was treated with FLUOROURACILE (598 Mg + 807 Mg) (View Fluorouracile Review and Fluorouracile Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ).

7013135-4 |
Adverse event was reported on Sep 21, 2010 by a Female patient taking Eloxatin (View Usage) (Dosage: ) . Location: UNITED STATES , 57 years of age, weighting 160.9 lb, . During the same period patient was treated with BEVACIZUMAB (Cycle 2, Day 15) (View Bevacizumab Review and Bevacizumab Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ).

7007020-1 | Diaphragmatic Paralysis, Diarrhoea, Dyspnoea, Nausea, Neck Pain, Stomatitis
on Sep 15, 2010 Male patient from UNITED STATES , 59 years of age, weighting 156.8 lb, was diagnosed with colon cancer and was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: diaphragmatic paralysis, diarrhoea, dyspnoea, nausea (What is nausea?), neck pain, stomatitis. Eloxatin dosage: 176 Mg Every Other Week. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), SODIUM DIATRIZOATE (View Sodium Diatrizoate Review and Sodium Diatrizoate Label ).


6986002-X | Blood Lactate Dehydrogenase Increased, Hepatic Enzyme Increased, Nausea
on Sep 08, 2010 Male patient from FRANCE , 56 years of age, was diagnosed with colon cancer and was treated with Eloxatin (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, hepatic enzyme increased, nausea (What is nausea?). Eloxatin dosage: . During the same period patient was treated with TOMUDEX (View Tomudex Review and Tomudex Label ).

6985283-6 | Atrial Fibrillation, Dyspnoea Exertional, Left Ventricular Failure, Tachycardia
Patient was taking Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), dyspnoea exertional, left ventricular failure, tachycardia on Sep 13, 2010 from ITALY Additional patient health information: Female patient , 74 years of age, . Eloxatin dosage: . During the same period patient was treated with PREFOLIC (View Prefolic Review and Prefolic Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6976286-6 | Cerebrovascular Accident, Dehydration, Diarrhoea
Adverse event was reported on Aug 31, 2010 by a Female patient taking Eloxatin (View Usage) (Dosage: ) . Location: SOUTH AFRICA , 56 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, dehydration, diarrhoea. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), BETANOID (View Betanoid Review and Betanoid Label ), CLOPAMON ^INTRAMED^ (View Clopamon ^intramed^ Review and Clopamon ^intramed^ Label ), CYCLIZINE HYDROCHLORIDE (View Cyclizine Hydrochloride Review and Cyclizine Hydrochloride Label ). Patient was hospitalized.

6975978-2 | Extrasystoles, Malaise, Muscle Spasms, Tachycardia, Tremor
on Aug 26, 2010 Female patient from FRANCE , 65 years of age, was diagnosed with rectal cancer and was treated with Eloxatin (View Usage). Patient had the following side effects: extrasystoles, malaise, muscle spasms, tachycardia, tremor. Eloxatin dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6972347-6 | Abasia, Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Activities Of Daily Living Impaired, Aphagia, Arthralgia, Ascites, Back Pain
on Sep 01, 2010 Female patient from UNITED STATES , 46 years of age, was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: abasia, abdominal discomfort, abdominal distension, abdominal pain upper, activities of daily living impaired, aphagia, arthralgia, ascites, back pain (What is back pain?). Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6960292-1 | Atrial Fibrillation, Dyspnoea Exertional, Left Ventricular Failure, Tachycardia
Patient was taking Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), dyspnoea exertional, left ventricular failure, tachycardia on Aug 30, 2010 from ITALY Additional patient health information: Female patient , 74 years of age, . Eloxatin dosage: . During the same period patient was treated with PREFOLIC (View Prefolic Review and Prefolic Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6955211-8 | Gastric Perforation, Peritonitis
Adverse event was reported on Aug 24, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with metastatic gastric cancer, gastroduodenal ulcer, antiemetic supportive care and. Location: KOREA, REPUBLIC OF , 50 years of age, weighting 155.6 lb, Patient had the following side effects: gastric perforation, peritonitis. During the same period patient was treated with SUNITINIB MALATE (Two Weeks On, One Week Off) (View Sunitinib Malate Review and Sunitinib Malate Label ), XELODA (View Xeloda Review and Xeloda Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6941970-7 | Arrhythmia
on Aug 23, 2010 Male patient from UNITED STATES , 65 years of age, weighting 183.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: arrhythmia (What is arrhythmia?). Eloxatin dosage: . During the same period patient was treated with CAPECITABINE (Day 1-14) (View Capecitabine Review and Capecitabine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), COMPAZINE (View Compazine Review and Compazine Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LOTEPREDNOL ETABONATE (View Loteprednol Etabonate Review and Loteprednol Etabonate Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ).

6931403-9 | Abasia, Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Activities Of Daily Living Impaired, Aphagia, Arthralgia, Ascites, Back Pain
on Aug 16, 2010 Female patient from UNITED STATES , 46 years of age, was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, abdominal discomfort, abdominal distension, abdominal pain upper, activities of daily living impaired, aphagia, arthralgia, ascites, back pain (What is back pain?). Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6927510-7 | Ileitis
Patient was taking Eloxatin (View Usage). Patient had the following side effects: ileitis on Aug 10, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Eloxatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), MONOCLONAL ANTIBODIES (View Monoclonal Antibodies Review and Monoclonal Antibodies Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6925037-X | Myocardial Infarction
Adverse event was reported on Aug 04, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with rectal cancer and. Location: UNITED STATES , 55 years of age, weighting 264.1 lb, After Eloxatin was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ), XELODA (View Xeloda Review and Xeloda Label ), THERAPEUTIC RADIOPHARMACEUTICALS (View Therapeutic Radiopharmaceuticals Review and Therapeutic Radiopharmaceuticals Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

6922436-7 | Abasia, Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Activities Of Daily Living Impaired, Aphagia, Arthralgia, Ascites, Back Pain
on Aug 06, 2010 Female patient from UNITED STATES , 46 years of age, was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, abdominal discomfort, abdominal distension, abdominal pain upper, activities of daily living impaired, aphagia, arthralgia, ascites, back pain (What is back pain?). Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6919115-9 | Cardiac Arrest, Convulsion, Erythema, Hot Flush, Loss Of Consciousness, Tremor, Vomiting
on Aug 09, 2010 Male patient from FRANCE , 59 years of age, weighting 163.1 lb, was treated with Eloxatin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), convulsion, erythema, hot flush, loss of consciousness, tremor, vomiting. Eloxatin dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), ZOPHREN (View Zophren Review and Zophren Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), CALCIUM (View Calcium Review and Calcium Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ). Patient was hospitalized.

6918068-7 | Abasia, Abdominal Discomfort, Abdominal Distension, Abdominal Pain Upper, Aphagia, Arthralgia, Ascites, Back Pain, Decreased Appetite
Patient was taking Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: abasia, abdominal discomfort, abdominal distension, abdominal pain upper, aphagia, arthralgia, ascites, back pain (What is back pain?), decreased appetite on Aug 02, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, . Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6913730-4 | Ileitis
Adverse event was reported on Jul 29, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: ileitis. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), MONOCLONAL ANTIBODIES (View Monoclonal Antibodies Review and Monoclonal Antibodies Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6907847-8 | Febrile Neutropenia, Myocardial Infarction
on Jul 26, 2010 Female patient from UNITED STATES , 66 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with Eloxatin (View Usage). Patient had the following side effects: febrile neutropenia, myocardial infarction. Eloxatin dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ERBITUX (View Erbitux Review and Erbitux Label ). Patient was hospitalized.

6899617-4 | Abasia, Abdominal Pain Upper, Aphagia, Arthralgia, Back Pain, Epistaxis, Fatigue
on Jul 26, 2010 Female patient from UNITED STATES , 46 years of age, was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: abasia, abdominal pain upper, aphagia, arthralgia, back pain (What is back pain?), epistaxis, fatigue. Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6880297-9 | Anaphylactic Reaction, Cardiac Disorder, Hypotension
Patient was taking Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, cardiac disorder, hypotension on Jul 21, 2010 from CANADA Additional patient health information: Male patient , 52 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?), anaphylactic reaction and. Eloxatin dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6879852-1 | Acute Coronary Syndrome, Dyspnoea Exertional
Adverse event was reported on Jul 27, 2010 by a Female patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: ITALY , 60 years of age, Patient had the following side effects: acute coronary syndrome, dyspnoea exertional. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), KYTRIL (View Kytril Review and Kytril Label ), PREFOLIC (View Prefolic Review and Prefolic Label ). Patient was hospitalized.

6870803-2 | Confusional State, Hypoxia, Lung Infiltration, Pyrexia
on Jul 13, 2010 Male patient from UNITED STATES , 51 years of age, was diagnosed with metastatic gastric cancer and was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: confusional state, hypoxia, lung infiltration, pyrexia. Eloxatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6867351-2 | Deep Vein Thrombosis, Factor V Leiden Mutation
on Jul 13, 2010 Female patient from GERMANY , 65 years of age, weighting 174.2 lb, was diagnosed with rectal cancer, prophylaxis and was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), factor v leiden mutation. Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), KEVATRIL (View Kevatril Review and Kevatril Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6831415-X | Colitis, Disseminated Intravascular Coagulation, Neutropenia, Pyrexia
Patient was taking Eloxatin (View Usage). Patient had the following side effects: colitis, disseminated intravascular coagulation, neutropenia, pyrexia on Jun 30, 2010 from IRELAND Additional patient health information: Male patient , 72 years of age, . Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), NEULASTA (View Neulasta Review and Neulasta Label ), CRESTOR (View Crestor Review and Crestor Label ), COZAAR (View Cozaar Review and Cozaar Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ). Patient was hospitalized.

6828350-X | Infusion Related Reaction, Product Substitution Issue
Adverse event was reported on Jul 08, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: 178mg Every 14 Days X 4 Iv) was diagnosed with rectal cancer and. Location: UNITED STATES , weighting 239.0 lb, After Eloxatin was administered, patient had the following side effects: infusion related reaction, product substitution issue.

6828164-0 | Infusion Related Reaction, Product Substitution Issue
on Jul 08, 2010 Female patient from UNITED STATES , weighting 194.0 lb, was diagnosed with rectal cancer and was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, product substitution issue. Eloxatin dosage: 167mg Over 2 Hours Iv, -one Time Every 14 Days X4-.

6816927-7 | Abdominal Abscess, Intestinal Fistula, Intestinal Perforation
on Jun 22, 2010 Male patient from SWITZERLAND , 68 years of age, was diagnosed with essential hypertension and was treated with Eloxatin (View Usage). Patient had the following side effects: abdominal abscess, intestinal fistula, intestinal perforation. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), AVASTIN (View Avastin Review and Avastin Label ), ENALAPRILAT (View Enalaprilat Review and Enalaprilat Label ). Patient was hospitalized.

6812300-6 | Anaemia, Angina Pectoris, Chest Pain, Dyspnoea, Fatigue, Hyperhidrosis, Insomnia, Nausea
Patient was taking Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: anaemia, angina pectoris, chest pain (What is chest pain?), dyspnoea, fatigue, hyperhidrosis, insomnia, nausea (What is nausea?) on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, weighting 231.5 lb, . Eloxatin dosage: Every 21 Days. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), COREG (View Coreg Review and Coreg Label ), COMPAZINE (View Compazine Review and Compazine Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6794796-1 | Cough, Dyspnoea, Pneumothorax, Pyrexia, Respiratory Distress
Adverse event was reported on Jun 24, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: 138 Mg Every 2 Weeks Iv) was diagnosed with colon cancer and. Location: UNITED STATES , 69 years of age, weighting 197.3 lb, Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, pneumothorax, pyrexia, respiratory distress. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), REMERON (View Remeron Review and Remeron Label ), CARDURA (View Cardura Review and Cardura Label ), NEXIUM (View Nexium Review and Nexium Label ), GLUCOSAMINE/CHONDROITIN (View Glucosamine/chondroitin Review and Glucosamine/chondroitin Label ).

6784259-1 | Toxic Epidermal Necrolysis
on Jun 15, 2010 Female patient from FRANCE , 18 years of age, was treated with Eloxatin (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Eloxatin dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), SORAFENIB (View Sorafenib Review and Sorafenib Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

6783888-9 | Dyspnoea, Laryngospasm
on Jun 18, 2010 Female patient from ITALY , 77 years of age, was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: dyspnoea, laryngospasm. Eloxatin dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TRIATEC (View Triatec Review and Triatec Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CLEXANE (View Clexane Review and Clexane Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6779496-6 | Acute Coronary Syndrome, Dyspnoea Exertional
Patient was taking Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, dyspnoea exertional on Jun 17, 2010 from ITALY Additional patient health information: Female patient , 60 years of age, was diagnosed with colon cancer and. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), KYTRIL (View Kytril Review and Kytril Label ), PREFOLIC (View Prefolic Review and Prefolic Label ). Patient was hospitalized.

6775216-X |
Adverse event was reported on Jun 14, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma metastatic and. Location: UNITED STATES , 65 years of age, weighting 183.0 lb, . During the same period patient was treated with CAPECITABINE (Day 1-14) (View Capecitabine Review and Capecitabine Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), COMPAZINE (View Compazine Review and Compazine Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LOTEPREDNOL ETABONATE (View Loteprednol Etabonate Review and Loteprednol Etabonate Label ), ONDANSETRON HYDROCHLORIDE (View Ondansetron Hydrochloride Review and Ondansetron Hydrochloride Label ).

6774881-0 | Lipase Increased, Transaminases Increased
on Jun 09, 2010 Female patient from GERMANY , 51 years of age, weighting 160.9 lb, was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: lipase increased, transaminases increased. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), EMEND (View Emend Review and Emend Label ).

6768081-8 | Acute Respiratory Distress Syndrome
on Jun 02, 2010 Female patient from LEBANON , 72 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome. Eloxatin dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6762962-7 | Condition Aggravated, Depressive Delusion
Patient was taking Eloxatin (View Usage). Patient had the following side effects: condition aggravated, depressive delusion on Jun 07, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ). Patient was hospitalized.

6760783-2 | Abdominal Pain Upper, Aphagia, Back Pain, Epistaxis, Fatigue, Hypersensitivity, Limb Deformity, Malignant Neoplasm Progression
Adverse event was reported on May 31, 2010 by a Female patient taking Eloxatin (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, After Eloxatin was administered, patient had the following side effects: abdominal pain upper, aphagia, back pain (What is back pain?), epistaxis, fatigue, hypersensitivity, limb deformity, malignant neoplasm progression. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ).

6760551-1 | Hypertensive Crisis, Proteinuria
on May 24, 2010 Male patient from ITALY , 52 years of age, was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis, proteinuria. Eloxatin dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6756855-9 | Anaemia, Angina Pectoris, Chest Pain, Dyspnoea, Fatigue, Hyperhidrosis, Insomnia, Nausea
on May 28, 2010 Male patient from UNITED STATES , 76 years of age, was treated with Eloxatin (View Usage). Patient had the following side effects: anaemia, angina pectoris, chest pain (What is chest pain?), dyspnoea, fatigue, hyperhidrosis, insomnia, nausea (What is nausea?). Eloxatin dosage: Every 21 Days. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), COREG (View Coreg Review and Coreg Label ), COMPAZINE (View Compazine Review and Compazine Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROPOXYPHENE (View Propoxyphene Review and Propoxyphene Label ).

6752468-3 | Cardiac Arrest
Patient was taking Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?) on May 28, 2010 from FRANCE Additional patient health information: Female patient , 81 years of age, was diagnosed with colon cancer and. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), LEVOFOLINATE DE CALCIUM WINTHROP (View Levofolinate De Calcium Winthrop Review and Levofolinate De Calcium Winthrop Label ).

6746368-2 | Blood Urine Present, Ill-defined Disorder
Adverse event was reported on May 24, 2010 by a Male patient taking Eloxatin (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 80 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: blood urine present, ill-defined disorder.

6744352-6 | Anaemia, Angina Pectoris, Chest Pain, Dyspnoea, Fatigue, Hyperhidrosis, Insomnia, Nausea
on May 20, 2010 Male patient from UNITED STATES , 76 years of age, was treated with Eloxatin (View Usage). Patient had the following side effects: anaemia, angina pectoris, chest pain (What is chest pain?), dyspnoea, fatigue, hyperhidrosis, insomnia, nausea (What is nausea?). Eloxatin dosage: Every 21 Days. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), COREG (View Coreg Review and Coreg Label ), COMPAZINE (View Compazine Review and Compazine Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROPOXYPHENE (View Propoxyphene Review and Propoxyphene Label ).

6706069-3 | Blood Amylase Increased
on Dec 03, 2009 Male patient from UNITED STATES , 60 years of age, was diagnosed with rectal cancer and was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: blood amylase increased. Eloxatin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6702563-X | Dyspnoea, Laryngospasm
Patient was taking Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, laryngospasm on Apr 28, 2010 from ITALY Additional patient health information: Female patient , 77 years of age, . Eloxatin dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLEXANE (View Clexane Review and Clexane Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6679841-6 | Gastric Varices, Portal Hypertension, Splenomegaly, Thrombocytopenia
Adverse event was reported on Apr 08, 2010 by a Female patient taking Eloxatin (View Usage) (Dosage: Dose:5 Milligram(s)/millilitre) was diagnosed with colon cancer and. Location: FRANCE , 44 years of age, weighting 119.0 lb, Patient had the following side effects: gastric varices, portal hypertension, splenomegaly, thrombocytopenia. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ELVORINE (View Elvorine Review and Elvorine Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ).

6677282-9 | Crohn's Disease
on Apr 05, 2010 Male patient from UNITED STATES , 70 years of age, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Eloxatin (View Usage). After Eloxatin was administered, patient had the following side effects: crohn's disease (What is crohn's disease?). Eloxatin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), MONOCLONAL ANTIBODIES (View Monoclonal Antibodies Review and Monoclonal Antibodies Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6673526-8 | Dermatitis Exfoliative, Eosinophilia, Erythema, Mouth Ulceration, Pruritus
on Mar 31, 2010 Male patient from FRANCE , 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Eloxatin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, eosinophilia, erythema, mouth ulceration, pruritus. Eloxatin dosage: Dose:5 Milligram(s)/millilitre. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), GEMZAR (View Gemzar Review and Gemzar Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6647064-2 | Atrial Flutter
Patient was taking Eloxatin (View Usage). Patient had the following side effects: atrial flutter on Mar 22, 2010 from ITALY Additional patient health information: Male patient , 68 years of age, was diagnosed with diffuse large b-cell lymphoma and. Eloxatin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), HOLOXAN (View Holoxan Review and Holoxan Label ), UROMITEXAN (View Uromitexan Review and Uromitexan Label ).